10 May Enovis Acquires Australian Orthopaedic Start-up 360 Med Care

SYDNEY, AUSTRALIA (9th May 2022) – Effective today, global medical technology company Enovis has acquired Australian orthopaedic company, 360 Med Care Pty Ltd, with the goal of creating better patient outcomes across the entire episode of orthopaedic care.

Enovis (formerly branded DJO) is a medical technology company with an extensive range of products and integrated technologies addressing the orthopaedic continuum of care from performance and mobility to surgical intervention and post-operative rehabilitation. This is the first acquisition since the rebrand of DJO to Enovis and has the potential for significant growth in the Australian market as well as internationally. 

“Enovis is focused on expanding our investment in innovation-driven Med Tech companies with synergies that align with our corporate mission of creating better together for healthcare professionals and their patients.” says Andrew Fox-Smith, President of International Business for Enovis. “We are excited to have 360 Med Care join our organisation. With their focus on continuous improvement, particularly through research and development that brings clinical benefit, they are a natural and welcome addition to the Enovis family.”

For Australian start-up company 360 Med Care, it is an opportunity to expand their surgical planning, delivery, and rehabilitation services to a worldwide market, especially the USA, which accounts for over half the world’s total joint replacements alone.

“It’s been a 10-year journey for 360 Med Care, from start-up to a 100 plus team, and we couldn’t have achieved this milestone without the financial support from AusIndustry, Federal and NSW grants for entrepreneurship and innovation, and the NSW Medical Devices Fund.” says Bede O’Connor, Managing Director for 360 Med Care. “The next stage of our journey is just beginning, as we combine our cultures, technologies and research with our Enovis family to continually improve and grow our offerings worldwide.” adds co-Founder and Chief Technology Officer Brad Miles PhD.

360 Med Care will now be ‘a technology of Enovis’, with the current team of engineers, researchers, machinists and physiotherapists across Australia, New Zealand, the USA, and India continuing to develop and deliver patient-specific solutions and technology for knee and hip joint replacement patients. The combination of recently acquired Mathys Orthopaedics’ Swiss quality implant products and 360 Med Care technologies will enhance the value to market for surgeons and patients alike. 

The businesses look forward to integrating their technology and capabilities for increased efficiencies and improved clinical outcomes, maintaining an aggressive growth strategy to develop opportunities in Australia and internationally.

……………

About Enovis

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopaedics and beyond. www.enovis.com.

About Mathys

Mathys AG Bettlach develops and distributes innovative products for artificial joint replacement, synthetic bone graft solutions, and sports medicine. Headquartered in Bettlach, Switzerland, Mathys has development and production sites in Switzerland and Germany, as well as subsidiaries in 11 countries, and has been part of the US-based company Enovis since 2021. https://www.mathysmedical.com.

About 360 Med Care

360 Med Care is an Australian orthopaedic company comprised of real people, combining knowledge and technology to positively impact the episode of care. Focused on innovation through rapid research and development, we create advancements that have clinical benefits based on a continuous cycle of surgeon and patient feedback. www.360med.care.

For more information, or to arrange an interview with Bede O’Connor or Andrew Fox-Smith, please contact:

Justine Drake

Enovis Marketing Manager ANZ Asia

+61 (0)423 921 098

Justine.Drake@enovis.com

SOURCE: PR Wire, May 9 2022

 To find our more news from the industry head over to our news section – orthocg.com/news